Skip to main navigation Skip to search Skip to main content

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.

  • Giovanni Martinotti
  • , Bernardo Dell"Osso
  • , Giorgio Di Lorenzo
  • , Giuseppe Maina
  • , Alessandro Bertolino
  • , Massimo Clerici
  • , Stefano Barlati
  • , Gianluca Rosso
  • , Marco Di Nicola
  • , Matteo Marcatili
  • , Giacomo d"Andrea
  • , Clara Cavallotto
  • , Stefania Chiappini
  • , Sergio De Filippis
  • , Giuseppe Nicolò
  • , Pasquale De Fazio
  • , Ileana Andriola
  • , Raffaella Zanardi
  • , Domenica Nucifora
  • , Stefania Di Mauro
  • Roberta Bassetti, Mauro Pettorruso, Roger S McIntyre, Stefano L Sensi, Massimo di Giannantonio, Antonio Vita, REAL-ESK Study Group

    Research output: Contribution to journalOriginal Articlepeer-review

    68 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)233-244
    Number of pages12
    JournalBIPOLAR DISORDERS
    Volume25
    Issue number3
    DOIs
    Publication statusPublished - May 2023

    Keywords

    • INTRAVENOUS KETAMINE
    • DOUBLE-BLIND
    • DISORDER
    • ANXIETY
    • ANTIDEPRESSANT
    • REMISSION
    • Ketamine/therapeutic use
    • Depressive Disorder, Treatment-Resistant/drug therapy
    • Humans
    • Antidepressive Agents/therapeutic use
    • Bipolar Disorder/drug therapy
    • Depression

    Cite this